Liver transplantation from living donors with Gilbert's syndrome is a safe procedure for both donors and recipients
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
Liver transplantation (LT) has become a favorable therapeutic option for patients with end-stage liver diseases. Gilbert's syndrome (GS) is a benign condition characterized by intermittent mild jaundice due to unconjugated hyperbilirubinemia. It is not obvious whether living-donor liver transplantation (LDLT) from a donor with GS could result in a normal outcome for both the recipient and the donor. We aimed to determine whether right lobe hepatectomy is a safe procedure for living donors with GS and LT recipients. Between September 2011 and March 2015, 305 LDLT procedures using right lobe grafts were performed at Atasehir Memorial Hospital, Istanbul, Turkey. Nineteen of 305 LT candidates who had been diagnosed with GS were included in the current study. After a 12-h overnight fast, total and indirect bilirubin levels of donors and recipients were measured. The median follow-up after transplant was 16 months (range 3-36 months). The median age of donors was 25 (range 20-55 yr). Four donors (21%) were female, and 15 donors (89%) were male. The median age of donors was 51 (range 23-68 yr). Eleven recipients (57%) were female, and 8 (43%) were male. The median preoperative total bilirubin level of donors was 1.69 mg/dL (range 1.26-2.43 mg/dL) (normal range <1.2 mg/dL). The median total bilirubin level of donors on postoperative day 7 was 1.04 mg/dL (range 0.71-3.23 mg/dL). As our study has included a large number of donors with GS, it produced reliable evidence that right lobe hepatectomy is a safe procedure for living donors with GS and LT recipients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Clinical transplantation - 29(2015), 11 vom: 14. Nov., Seite 965-70 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tanoglu, Alpaslan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Gilbert's syndrome |
---|
Anmerkungen: |
Date Completed 09.08.2016 Date Revised 28.10.2015 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/ctr.12615 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM251814688 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM251814688 | ||
003 | DE-627 | ||
005 | 20231224162818.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/ctr.12615 |2 doi | |
028 | 5 | 2 | |a pubmed24n0839.xml |
035 | |a (DE-627)NLM251814688 | ||
035 | |a (NLM)26271485 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tanoglu, Alpaslan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Liver transplantation from living donors with Gilbert's syndrome is a safe procedure for both donors and recipients |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.08.2016 | ||
500 | |a Date Revised 28.10.2015 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
520 | |a Liver transplantation (LT) has become a favorable therapeutic option for patients with end-stage liver diseases. Gilbert's syndrome (GS) is a benign condition characterized by intermittent mild jaundice due to unconjugated hyperbilirubinemia. It is not obvious whether living-donor liver transplantation (LDLT) from a donor with GS could result in a normal outcome for both the recipient and the donor. We aimed to determine whether right lobe hepatectomy is a safe procedure for living donors with GS and LT recipients. Between September 2011 and March 2015, 305 LDLT procedures using right lobe grafts were performed at Atasehir Memorial Hospital, Istanbul, Turkey. Nineteen of 305 LT candidates who had been diagnosed with GS were included in the current study. After a 12-h overnight fast, total and indirect bilirubin levels of donors and recipients were measured. The median follow-up after transplant was 16 months (range 3-36 months). The median age of donors was 25 (range 20-55 yr). Four donors (21%) were female, and 15 donors (89%) were male. The median age of donors was 51 (range 23-68 yr). Eleven recipients (57%) were female, and 8 (43%) were male. The median preoperative total bilirubin level of donors was 1.69 mg/dL (range 1.26-2.43 mg/dL) (normal range <1.2 mg/dL). The median total bilirubin level of donors on postoperative day 7 was 1.04 mg/dL (range 0.71-3.23 mg/dL). As our study has included a large number of donors with GS, it produced reliable evidence that right lobe hepatectomy is a safe procedure for living donors with GS and LT recipients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Gilbert's syndrome | |
650 | 4 | |a hyperbilirubinemia | |
650 | 4 | |a living-donor liver transplantation | |
650 | 4 | |a recipient | |
650 | 4 | |a right hepatectomy | |
700 | 1 | |a Artis, Tarik |e verfasserin |4 aut | |
700 | 1 | |a Donmez, Ramazan |e verfasserin |4 aut | |
700 | 1 | |a Kargi, Ahmet |e verfasserin |4 aut | |
700 | 1 | |a Sit, Mustafa |e verfasserin |4 aut | |
700 | 1 | |a Aslan, Serdar |e verfasserin |4 aut | |
700 | 1 | |a Yazar, Serafettin |e verfasserin |4 aut | |
700 | 1 | |a Beyazit, Yavuz |e verfasserin |4 aut | |
700 | 1 | |a Polat, Kamil Yalcin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical transplantation |d 1987 |g 29(2015), 11 vom: 14. Nov., Seite 965-70 |w (DE-627)NLM07493306X |x 1399-0012 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2015 |g number:11 |g day:14 |g month:11 |g pages:965-70 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/ctr.12615 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2015 |e 11 |b 14 |c 11 |h 965-70 |